Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1ZG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,715
Award facts
- Contract value 100% obligated
- $14,715.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,715.06 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400-milliliter immunoglobulin vial product. This firm fixed-price delivery order, issued on December 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance will be completed by December 30, 2025. AmerisourceBergen's place of performance is listed in Conshohocken, Pennsylvania, the company's headquarters location.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications, vaccines, and medical devices to military and veteran healthcare systems. The company's DLA Troop Support Medical contract vehicle functions as a global pharmaceutical support program enabling delivery of specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency requirements and other federal healthcare systems. This delivery order for GAMUNEX-C, an immunoglobulin replacement therapy product, reflects the company's ongoing role in fulfilling critical pharmaceutical needs across the defense healthcare network.
Quick answers
Who was awarded contract SPE2DR26FG1ZG?
SPE2DR26FG1ZG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FG1ZG worth?
The government has obligated $14,715 on SPE2DR26FG1ZG.
Is contract SPE2DR26FG1ZG an order under another contract?
Yes. SPE2DR26FG1ZG is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1ZG competed?
The extent of competition for SPE2DR26FG1ZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award